Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Degenerative neurological disorders

Benzodiazepines linked to risk of Alzheimer’s disease

Although data showed benzodiazepine and Z drug use was linked to only a 6% increase in the odds of developing Alzheimer’s disease, researchers say their prescribing should be avoided if possible.

Benzodiazepines - Clonazolam pills spilled on table

Source: Wikimedia Commons

Researchers found that use of benzodiazepines and related drugs (Z drugs) was associated with a 6% increase in the odds of developing Alzheimer’s disease

Benzodiazepines and related drugs (Z drugs) are associated with a modestly increased risk of developing Alzheimer’s disease (AD), according to the results of a Finnish study[1].

The study, published in Acta Psychiatrica Scandinavica (online, 31 May 2018), included data on 70,719 people diagnosed with AD between 2005 and 2011 and compared them with 282,862 matched controls without AD. It also looked at benzodiazepine and related drug use since 1995.

The researchers found that use of benzodiazepines and related drugs was associated with a 6% increase in the odds of developing AD. There was a dose–response relationship between benzodiazepine and related drug use and AD risk, but this disappeared when adjusted for other psychotropic use, suggesting that the association could be partially explained by other psychotropics or concomitant use of these medicines.

The team said the findings were important because benzodiazepines were commonly prescribed to older people. The drugs were associated with short-term negative effects on memory and cognition, as well as drowsiness, falls and hip fractures.

“Even though association between [benzodiazepine and related drug] use and AD was modest in this study, [benzodiazepines and related drugs] should be avoided if possible and threshold for prescribing should be high enough due to overall adverse effect profile of the [benzodiazepines and related drugs],” they concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205526

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Benzodiazepines - Clonazolam pills spilled on table

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.